Literature DB >> 26598495

Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.

Ian F Kimbrough1, Stefanie Robel1, Erik D Roberson2, Harald Sontheimer3.   

Abstract

Reduced cerebral blood flow impairs cognitive function and ultimately causes irreparable damage to brain tissue. The gliovascular unit, composed of neural and vascular cells, assures sufficient blood supply to active brain regions. Astrocytes, vascular smooth muscle cells, and pericytes are important players within the gliovascular unit modulating vessel diameters. While the importance of the gliovascular unit and the signals involved in regulating local blood flow to match neuronal activity is now well recognized, surprisingly little is known about this interface in disease. Alzheimer's disease is associated with reduced cerebral blood flow. Here, we studied how the gliovascular unit is affected in a mouse model of Alzheimer's disease, using a combination of ex vivo and in vivo imaging approaches. We specifically labelled vascular amyloid in living mice using the dye methoxy-XO4. We elicited vessel responses ex vivo using either pharmacological stimuli or cell-specific calcium uncaging in vascular smooth muscle cells or astrocytes. Multi-photon in vivo imaging through a cranial window allowed us to complement our ex vivo data in the presence of blood flow after label-free optical activation of vascular smooth muscle cells in the intact brain. We found that vascular amyloid deposits separated astrocyte end-feet from the endothelial vessel wall. High-resolution 3D images demonstrated that vascular amyloid developed in ring-like structures around the vessel circumference, essentially forming a rigid cast. Where vascular amyloid was present, stimulation of astrocytes or vascular smooth muscle cells via ex vivo Ca(2+) uncaging or in vivo optical activation produced only poor vascular responses. Strikingly, vessel segments that were unaffected by vascular amyloid responded to the same extent as vessels from age-matched control animals. We conclude that while astrocytes can still release vasoactive substances, vascular amyloid deposits render blood vessels rigid and reduce the dynamic range of affected vessel segments. These results demonstrate a mechanism that could account in part for the reduction in cerebral blood flow in patients with Alzheimer's disease.media-1vid110.1093/brain/awv327_video_abstractawv327_video_abstract.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; amyloidosis; multi-photon imaging; neurovascular coupling; vascular amyloid

Mesh:

Substances:

Year:  2015        PMID: 26598495      PMCID: PMC5006220          DOI: 10.1093/brain/awv327

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  68 in total

1.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

2.  Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds.

Authors:  Nelly Joseph-Mathurin; Olène Dorieux; Stéphanie G Trouche; Allal Boutajangout; Audrey Kraska; Pascaline Fontès; Jean-Michel Verdier; Einar M Sigurdsson; Nadine Mestre-Francés; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2013-06-22       Impact factor: 4.673

3.  Tone-dependent vascular responses to astrocyte-derived signals.

Authors:  Víctor M Blanco; Javier E Stern; Jessica A Filosa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

4.  Tuning caged calcium: photolabile analogues of EGTA with improved optical and chelation properties.

Authors:  Graham C R Ellis-Davies; Robert J Barsotti
Journal:  Cell Calcium       Date:  2005-11-21       Impact factor: 6.817

Review 5.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

6.  Ultrastructural observations of astrocyte end-feet in the rat central nervous system.

Authors:  E Nakazawa; H Ishikawa
Journal:  J Neurocytol       Date:  1998-06

7.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

8.  Stimulation-evoked Ca2+ signals in astrocytic processes at hippocampal CA3-CA1 synapses of adult mice are modulated by glutamate and ATP.

Authors:  Wannan Tang; Karolina Szokol; Vidar Jensen; Rune Enger; Chintan A Trivedi; Øivind Hvalby; P Johannes Helm; Loren L Looger; Rolf Sprengel; Erlend A Nagelhus
Journal:  J Neurosci       Date:  2015-02-18       Impact factor: 6.167

9.  Assembly of a perivascular astrocyte protein scaffold at the mammalian blood-brain barrier is dependent on alpha-syntrophin.

Authors:  April D Bragg; Mahmood Amiry-Moghaddam; Ole P Ottersen; Marvin E Adams; Stanley C Froehner
Journal:  Glia       Date:  2006-06       Impact factor: 7.452

10.  Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation.

Authors:  Micaela Zonta; María Cecilia Angulo; Sara Gobbo; Bernhard Rosengarten; Konstantin-A Hossmann; Tullio Pozzan; Giorgio Carmignoto
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

View more
  50 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.

Authors:  Emily L Munger; Melissa K Edler; William D Hopkins; John J Ely; Joseph M Erwin; Daniel P Perl; Elliott J Mufson; Patrick R Hof; Chet C Sherwood; Mary Ann Raghanti
Journal:  J Comp Neurol       Date:  2019-01-07       Impact factor: 3.215

3.  Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice.

Authors:  Christopher J Yuskaitis; Leigh-Ana Rossitto; Sarika Gurnani; Elizabeth Bainbridge; Annapurna Poduri; Mustafa Sahin
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

Review 4.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

5.  Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases.

Authors:  Margarita Arango-Lievano; Patrizia Giannoni; Sylvie Claeysen; Nicola Marchi; Freddy Jeanneteau
Journal:  J Vis Exp       Date:  2016-12-06       Impact factor: 1.355

Review 6.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

7.  Susceptibility of brain atrophy to TRIB3 in Alzheimer's disease, evidence from functional prioritization in imaging genetics.

Authors:  Marco Lorenzi; Andre Altmann; Boris Gutman; Selina Wray; Charles Arber; Derrek P Hibar; Neda Jahanshad; Jonathan M Schott; Daniel C Alexander; Paul M Thompson; Sebastien Ourselin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-06       Impact factor: 11.205

8.  Selective knockout of astrocytic Na+ /H+ exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke.

Authors:  Gulnaz Begum; Shanshan Song; Shaoxia Wang; Hanshu Zhao; Mohammad Iqbal H Bhuiyan; Eric Li; Rachel Nepomuceno; Qing Ye; Ming Sun; Michael Joseph Calderon; Donna B Stolz; Claudette St Croix; Simon C Watkins; Yinhuai Chen; Pingnian He; Gary E Shull; Dandan Sun
Journal:  Glia       Date:  2017-09-19       Impact factor: 7.452

Review 9.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

10.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease.

Authors:  Anna Csiszar; Stefano Tarantini; Gábor A Fülöp; Tamas Kiss; M Noa Valcarcel-Ares; Veronica Galvan; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2017-08-29       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.